GLP-1 drugs are reshaping food spending habits, study finds
As Stacey Leasca reports for “Food & Wine,” research from Cornell University found that households with at least one GLP-1 ...
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Zacks.com on MSN12d
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise
Shares of Novo Nordisk and Eli Lilly gain following study results that show GLP-1 drugs cut the risk of heart and kidney ...
Roche Q4 Earnings Review: Solid All-Court Performance, But Quiet On GLP-1 Progress
Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...
6 Common Side Effects from Taking a GLP-1 Medication—and How to Manage Them
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...
Pharm Exec13d
Novel GLP-1 Receptor Agonist Demonstrates Promising Results Treating Patients with Obesity
Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a ...
ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI
ImmunoPrecise Antibodies (IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance efficacy, safety, therapy longevity, and patient satisfaction ...
AOL14d
GLP-1 Drugs Benefit Brain and Heart Health, but May Cause Kidney, GI Issues
Ozempic, Wegovy, Mounjaro, and Zepbound are all classified as GLP-1 drugs. These medications, which are taken by injection, work by simulating naturally produced hormones that curb appetite and ...